Back to top

MBX Biosciences CEO Kent Hawryluk steps down, Steve Hoerter succeeds

MBX Biosciences (MBX) announced that its board of directors has appointed Steve Hoerter, current executive chairman of the board, as its new chairm...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE: